Juvenile Dermatomyositis Clinical Trials

28 clinical trials for Juvenile Dermatomyositis across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) — RECRUITING · PHASE2
• Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders — RECRUITING · PHASE1
• RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy — RECRUITING · PHASE2
• Environmental Risk Factors for the Anti-synthetase Syndrome — RECRUITING
• MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS) — RECRUITING
• Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases — RECRUITING · PHASE1
• Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis — RECRUITING · PHASE1
• Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis — COMPLETED
• COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders — TERMINATED · PHASE2
• Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT) — COMPLETED · PHASE2
• Comparison Of The Effects Of Two Different Exercise Training Based On Internal And External Focus In Children and Adolescents With Rheumatic Diseases — COMPLETED · NA
• Transition to Adulthood Through Coaching and Empowerment in Rheumatology — COMPLETED · NA
• Activity monitoring in adolescents and young adults with inflammatory rheumatic musculoskeletal diseases (ActiMON) — OTHER
• Fitness Integrative Training for Pediatric Rheumatology Disorders — COMPLETED · NA
• Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes — OTHER
• MYOCIT - Baricitinib in the treatment of new-onset juvenile dermatomyositis: a phase II trial — OTHER · PHASE2
• Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis — COMPLETED · PHASE4
• Testing the sensitivity and specificity of EUROLINE immunoblots for systemic sclerosis and autoimmune muscle diseases — OTHER
• Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis — COMPLETED · PHASE3
• Clinical Analysis of Juvenile Dermatomyositis Patients — COMPLETED
• Yellow Fever Vaccine in Patients With Rheumatic Diseases — COMPLETED · NA
• The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis — COMPLETED · NA
• Juvenile Dermatomyositis — OTHER
• Incidence and Prevalence of Juvenile Dermatomyositis — OTHER
• Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease — COMPLETED · PHASE4
• The CARRA Registry — COMPLETED
• Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) — COMPLETED · PHASE2
• Creatine Supplementation in Pediatric Rheumatology — OTHER · NA

Refine this search